Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, announced the acquisition of Biologos LLC, a full-service manufacturer of custom and standard cell culture media, reagents, buffers, enzymes, and sera.
March 19, 2024
· 2 min read
